Initial data looking at safety and efficacy of an interatrial septal occluder with a bioresorbable frame show promise for closing atrial septal defects (ASDs), but the study authors suggest a redesign ...

Please provide your email address to receive an email when new articles are posted on . Supraventricular arrhythmias may be underestimated in patients who have received percutaneous patent foramen ...

Study honoraria to institution, travel expenses, consulting fees - Abbott; Bioventrix; CVRx; Boston Scientific Corporation; Lifetech; Occlutech; Vascular Dynamics; Recor Medical Receive the the latest ...

The research was designed to determine the PFO closure rate, procedure-related complications, the recurrence of AF, and stroke/TIA events. Patients who underwent AS cryoablation had a significantly ...

SAN FRANCISCO, CA — Using a device designed to close the patent foramen ovale (PFO) in patients who have had a cryptogenic ischemic stroke may reduce their risk of having another stroke, suggests ...

Announcing a new article publication for Cardiovascular Innovations and Applications journal. Atrial septal aneurysm (ASA) is defined as excursion of the atrial septum exceeding 10 mm beyond the ...

It has been well established that device closure has, on average, prevented stroke recurrence in people who’ve had patent foramen ovale–associated stroke, but a meta-analysis has drilled down into ...

While other device-based closures have demonstrated notable rates of atrial fibrillation (5.7–6.6%) and device-related adverse events, the NobleStitch™ system's fully suture-mediated approach ...

Current evidence on the efficacy of percutaneous closure of patent foramen ovale (PFO) for the secondary prevention of recurrent paradoxical embolism in divers is inadequate in quality and quantity, ...

Jun. 17—THOMASVILLE- Archbold Interventional Cardiologist Jared Davis, MD, recently performed a cutting-edge cardiac procedure that offers treatment for a common silent heart condition that can lead ...